Table 1.

Mean PFOA and PFOA-fluorine equivalent concentrations (ng/μl F or μg/g F) of measured PFOA and extractable organofluorine (EOF) in terminal plasma, lung lavage, and organs sample

Matrix	PFOA1		PFOA-fluorine equivalent2		EOF2		Contribution to EOF (%)
	Inhalation	Oral	Inhalation	Oral	Inhalation	Oral	Inhalation	Oral
Plasma	1.97 ± 0.32	1.87 ± 0.35	1.53 ±0.17	1.42 ±0.24	2.15 ±0.03	2.18 ±0.13	71	65
Lung lavage	9.98 ± 0.63	0.31 ± 0.02	6.87 ± 0.43	0.21 ± 0.02	9.01 ± 0.67	0.25 ± 0.02	76	84
Liver	10.1 ± 0.9	8.94 ± 0.5	6.95 ± 0.65	6.14 ± 0.34	7.97 ± 0.69	7.36 ± 0.36	87	83
Lung	31.3 ± 4.0	1.68 ± 0.3	21.5 ± 2.75	1.16 ± 0.21	24.9 ± 2.76	1.55 ± 0.28	86	74
Kidney	3.84 ± 0.8	3.15 ± 0.2	2.64 ± 0.53	2.16 ± 0.13	3.26 ± 0.65	2.63 ± 0.18	81	83
Liver:plasmaa	5.28 ± 1.3	4.89 ± 1.0
Kidney:plasmaa	2.02 ± 0.7	1.72 ± 0.3

¹Concentration is present in ng/μl for plasma and lung lavage and μg/g for organ samples. ²Concentration is present in ng/μl F for plasma and lung lavage and μg/g F for organ sample. ^aRatio